Overview
Thromboprophylaxis and Bariatric Surgery
Status:
Unknown status
Unknown status
Trial end date:
2012-12-01
2012-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery. - gastric banding and gastric bypass on anti-Xa activity levels The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass. Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University Hospital, Strasbourg, FranceCollaborators:
French State
SanofiTreatments:
Enoxaparin
Criteria
Inclusion Criteria:- BMI over 40
- Gastric banding or gastric bypass
Exclusion Criteria:
- Renal insufficiency
- Thrombopenia
- Long term anticoagulant treatment
- Pregnancy
- Allergy to heparin